SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-001104
Filing Date
2022-02-14
Accepted
2022-02-14 16:21:54
Documents
107
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q ibio-20211231x10q.htm   iXBRL 10-Q 2678424
2 EX-31.1 ibio-20211231xex31d1.htm EX-31.1 18168
3 EX-31.2 ibio-20211231xex31d2.htm EX-31.2 17855
4 EX-32.1 ibio-20211231xex32d1.htm EX-32.1 7616
5 EX-32.2 ibio-20211231xex32d2.htm EX-32.2 6578
6 GRAPHIC ibio-20211231x10q001.jpg GRAPHIC 75109
  Complete submission text file 0001558370-22-001104.txt   12174132

Data Files

Seq Description Document Type Size
7 EX-101.SCH ibio-20211231.xsd EX-101.SCH 95620
8 EX-101.CAL ibio-20211231_cal.xml EX-101.CAL 100408
9 EX-101.DEF ibio-20211231_def.xml EX-101.DEF 263853
10 EX-101.LAB ibio-20211231_lab.xml EX-101.LAB 605033
11 EX-101.PRE ibio-20211231_pre.xml EX-101.PRE 544614
101 EXTRACTED XBRL INSTANCE DOCUMENT ibio-20211231x10q_htm.xml XML 2590354
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 22632518
SIC: 2834 Pharmaceutical Preparations